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ABSTRACT
Background and Objectives: To report the feasibility
and safety of the use of a novel energy source that uses an
electrically neutral beam of pure argon plasma for the
laparoscopic management of endometriosis.
Methods: In this prospective pilot study, 20 patients un-
dergoing laparoscopic treatment of endometriosis were
included. Characteristic endometriotic lesions throughout
the pelvis were vaporized or resected using neutral argon
plasma. Specimens were evaluated for the presence of
endometriosis and thermal effects on tissue. The bases of
the treated lesions were biopsied to determine whether
residual endometriosis was present.
Results: Neutral argon plasma was used in 18 of the 20
patients for laparoscopic treatment of pelvic endometrio-
sis. All biopsies confirmed complete vaporization or re-
section with no residual endometriosis at the base. Endo-
metriosis was identified on pathology in all lesions
excised. Thermal effects did not interfere with histologic
analysis in any of the lesions. No complications occurred.
Conclusion: Neutral argon plasma can be utilized as a
multi-functional device that has vaporization, coagulation,
and superficial cutting capacities with minimal thermal
spread and acceptable outcomes. The use of neutral argon
plasma appears to be efficacious and safe for the complete
treatment of endometriotic implants.
Key Words: Endometriosis, Neutral argon plasma, Exci-
sion of endometriosis, Vaporization of endometriosis.
INTRODUCTION
Endometriosis is the implantation of endometrial-type
cells outside of the uterine cavity. The condition is asso-
ciated with chronic pain, diminished quality of life, sub-
fertility, psychological morbidity, and work absentee-
ism.1,2 It is the third leading cause of gynecologic
hospitalizations3 and mainly affects reproductive-aged
women. It is found in up to 50% of women with infertility4
and up to 70% of adolescents with pelvic pain recalcitrant
to conservative measures.5
Because lesions are usually undetectable by examination,
preoperative laboratory tests, or imaging techniques, ac-
tual operative visualization and sampling of lesions is
necessary to diagnose the disease. Thus, surgical assess-
ment by either laparoscopy or laparotomy for simulta-
neous diagnosis and treatment of endometriosis has be-
come the “gold standard.” Surgical treatment may consist
of excision, vaporization, coagulation of lesions, or all of
these. Multiple instruments have been used for the surgi-
cal management of endometriosis including scissors, bi-
polar and monopolar electrosurgery, ultrasonic energy,
and lasers.
The PlasmaJet system (PJS), developed by Plasma Surgical
Limited (Theale, Berkshire, UK), gained FDA approval as
a coagulation device in 2004 and provides an electrically
neutral stream of ionized argon gas. The system emits a
high-energy jet of argon plasma possessing thermal and
kinetic energy that can be used to coagulate a tissue
surface including small vessels and lymphatics. Since its
introduction, PlasmaJet has been used safely in both open
and endoscopic cases in orthopedics, oncology, gastroen-
terology, liver surgery, plastic surgery of the abdomen and
face, and in thoracic surgery.
We report our initial experience using this novel energy
source for the laparoscopic management of endometrio-
sis.
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SCIENTIFIC PAPERMETHODS
From April to December 2008, 20 patients with surgically
diagnosed endometriosis were selected. The hospital’s
Institutional Review Board granted exempt status to this
study.
All patients underwent general anesthesia and multi-
puncture operative laparoscopy as previously described.6
Characteristic endometriotic lesions throughout the pelvis
were vaporized or resected with the PJS at 100% power
using high-temperature and high-gas flow. For vaporiza-
tion, the probe was directed at the lesions from a distance
of close to 5mm, spraying the tissue surface at an angle of
approximately 45 degrees until the tissue surface demon-
strated a characteristic silver, shiny appearance and there
was visual confirmation of complete eradication of the
lesions. Tissue surfaces were irrigated continuously with
lactated ringers, removing debris from the area. The bases
of these lesions were then biopsied with sharp scissors to
determine whether residual endometriosis was present. In
delicate areas, such as the ovarian cortex, fallopian tubes,
paraureter, bladder, and bowel serosa, lesions were visu-
ally identified and vaporized and irrigated until the ap-
pearance of underlying healthy tissue, without performing
a biopsy.
Other lesions were resected using the PJS as a cutting
instrument. The probe was placed closer to the tissue
surface at approximately a 90-degree angle. After excision
with visual judgment of complete treatment, biopsies at
the site of the excised lesions were obtained sharply with
scissors. Both the lesion and biopsy of the posttreatment
lesion site were sent to pathology for evidence of endo-
metriosis, as well as for thermal effects on the specimen.
One patient underwent second-look laparoscopy for ad-
hesions 7 weeks after her initial surgery during which
neutral argon plasma was used for the treatment of endo-
metriosis. Sites where the PJS was utilized during the first
procedure were biopsied. The tissue was evaluated for
nonvisible residual endometriosis and posttreatment de-
scriptive healing.
RESULTS
Neutral argon plasma was intended for use in 20 patients,
and actually used in 18 patients, for laparoscopic treat-
ment of pelvic endometriotic lesions. All procedures were
completed as planned, though in 2 cases equipment fail-
ure was encountered before initiation of treatment.
All study participants were women with a mean age of 32
years (range, 20 to 49). Mean BMI was 23.9kg/m
2 (range,
21 to 29), mean gravidity was 0.9 (range, 0 to 5), and mean
parity was 0.4 (range, 0 to 3). During surgery, all patients
were assigned an endometriosis stage according to the
1996 revised American Society for Reproductive Medicine
classifications7; 5 patients had stage I endometriosis, 5 had
Stage II, 4 had Stage III, and 4 had Stage IV disease. Seven
patients had been diagnosed with endometriosis during a
previous surgery. None of the patients had significant past
medical histories.
A total of 46 lesions were safely vaporized or excised with
neutral argon plasma in locations including the anterior
cul-de-sac (15), ovaries (10), posterior cul-de-sac (7), pel-
vic sidewalls (7), pararectal spaces (2), fallopian tubes (2),
broad ligament (1), uterine serosa (1), and rectal serosa
(1).
Twenty-seven lesions were vaporized. Seven posttreat-
ment lesion sites were biopsied, and all biopsy specimens
confirmed complete vaporization with no residual endo-
metriosis at the base of the lesion.
Nineteen lesions were resected using the PJS as a cutting
instrument. In all 19 (100%) specimens, endometriosis
was identified on pathology. Thermal effects did not in-
terfere with histologic analysis in any of the lesions. At 8
of these sites, biopsy of the posttreatment lesion site was
obtained with 100% confirmation of complete resection
with no residual endometriosis at the base.
The patient who underwent a second-look laparoscopy 7
weeks after the initial treatment had no residual endome-
triosis at her previously treated sites. At second-look,
these sites were reperitonealized and free of adhesions.
Histology of these previously treated sites revealed fibroa-
dipose tissue with reactive fibrosis and foreign body re-
action and no endometriosis.
All procedures were performed in an outpatient setting.
All patients were discharged within 23 hours postopera-
tively. There were no intraoperative or postoperative
complications.
DISCUSSION
Plasma is often described as the fourth state of matter,
consisting of ionized gas in the form of high-energy par-
ticles. The PJS generates argon plasma by concentrating a
low flow of inert argon gas within an insulated handpiece
that contains bipolar electrodes. A low voltage of approx-
imately 30V to 60V ionizes the argon gas, thereby produc-
ing electrically neutral, high-energy argon plasma that is
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stream. Possessing thermal, kinetic, and light energies, the
jet of plasma first blows away debris, tissue, and blood
from the point of application. A thin, flexible coagulum is
then formed that seals the tissue surface. Animal studies
have demonstrated a depth of penetration between
0.5mm to 2.0mm, depending on duration of application of
the jet to tissue (Y. Parhomenko, S. Tartynsky, K.
Kachiken, unpublished data).
With both monopolar electrosurgery and argon beam co-
agulation, the current is applied to the tissue and leads to
coagulation through combined effects of heating and arc
generation between an active electrode and grounded
tissue. Arcing vaporizes tissue and results in small fissures
in tissue created by sparks, which allow for deeper tissue
destruction as current flows along a tissue’s path of least
resistance.8,9 Argon-enhanced tissue fulguration causes
tissue effects that depend on the electrical characteristics
of tissue, its physical composition, and degree of vascular
perfusion.10 In contrast, the neutral argon plasma device
emits an electrically neutral plasma jet, with no current
flowing through the patient, and tissue penetration re-
mains minimal. The device behaves in a similar way to the
CO2 laser as it desiccates and effectively vaporizes tissue
by forming a series of layers of eschar without sparking,
and thus without disruption of the coagulum. This is
purported to provide a more effective, homogenous bar-
rier to further bleeding (Y. Parhomenko, S. Tartynsky, K.
Kachiken, unpublished data). Additionally, the PJS uses
approximately 10% of the gas flow used by the argon
beam coagulator; typical gas flow is less than 0.4L/min,
thus theoretically decreasing the risk for air embolism and
intraperitoneal overpressure (Table 1).
Early use of the PJS in several unpublished pilot studies
has demonstrated safe application in both open and en-
doscopic cases in orthopedics, oncology, gastroenterol-
ogy, liver surgery, plastic surgery of the abdomen and
face, and in thoracic surgery (Y. Parhomenko, S. Tartyn-
sky, K. Kachiken and J. Gugenheim, A. Ianielli, unpub-
lished data).11,12 Most analogous to endometriosis, ovarian
cancer has been treated with neutral argon plasma. An
investigation11 of its applicability in cytoreduction for
ovarian cancer demonstrated that the device effectively
vaporized ovarian and peritoneal cancer cells while main-
taining minimal thermal spread. The ex-vivo study of
high-grade serous omental tumors revealed thermal dam-
age to be approximately 5% of the depth of tissue vapor-
ization. With exposures of 2 seconds to 4 seconds on
standard settings, vaporization depths varied from 0.9 mm
to 6.1 mm (mean 2.7; SD 1.3).
This technology is applicable to the treatment of endome-
triosis, as lesions are frequently superficial peritoneal im-
plants that are diagnosed on visualization. The depth of
involvement in underlying tissue may be visualized by
characteristic expression of chocolate fluid or fibrosis. The
goal of treatment is to completely eliminate these lesions
when appropriate.13
The vaporization technique used during treatment of en-
dometriosis is analogous to that used when other energy
sources are used. In an “onion peel fashion,” layer by
layer treatment of lesions is performed from superficial to
deep layers, while alternating vaporization with irrigation
until underlying healthy tissue is identified (Figures 1
and 2). Our experience reveals that this method of visual
inspection accurately determines adequacy of treatment.
Table 1.
Comparison of Argon Beam Coagulator and Neutral Argon Plasma
Argon Beam Coagulator Neutral Argon Plasma (PJS)
Inert argon gas 4–7 L/min 0.4 L/min
Risks Air embolism; Overpressure Minimized
Thermal
spread
4–10 mm 0.5–2 mm
Voltage 5000–9000 30–60
Current flow Active electrode, requires grounding pad; Similar
to monopolar electrosurgery
Electrically neutral, no electricity passes to the
patient Comparable to bipolar electrosurgery
Applications Coagulation Vaporization, cutting, small vessel coagulation
Surgical use No direct contact with tissue No direct contact with tissue
Visual cues Blue spray Light blue glow
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vaporized or resected using neutral argon plasma, re-
vealed no residual disease when the posttreatment lesion
sites were biopsied sharply. Furthermore, during a sec-
ond-look procedure, in a patient with Stage IV endome-
triosis, the endometriotic lesions to which neutral argon
plasma were applied during the first procedure demon-
strated a fibroadipose healing process with no further
evidence of adhesions or disease when rebiopsied 7
weeks postoperatively.
Neutral argon plasma may also be used as a cutting device
for tissue resection by placing the jet in close proximity to
tissue. All visually confirmed endometriotic lesions that
were biopsied using the PJS were pathologically con-
firmed as endometriosis. Histopathological analysis of re-
sected lesions demonstrated 1-mm lateral thermal
spread, causing minimal specimen damage (Figures 3
and 4). These findings are consistent with findings in
earlier studies that demonstrated minimal thermal spread,
and thus minimal tissue destruction to biopsy specimens
(Y. Parhomenko, S. Tartynsky, K. Kachiken, unpublished
data).11 Also notable, all areas of resection and vaporiza-
tion were hemostatic after application of neutral argon
plasma. These findings confirm earlier human and animal
Figure 3. Hematoxyline-eosin stained micrograph demonstrat-
ing 1 mm lateral thermal spread.
Figure 4. Area of thermal spread 1 mm.
Figure 1. Endometriotic lesions on peritoneal surfaces of uterus
and bladder.
Figure 2. Site of endometriotic lesions uterine and bladder
surfaces after vaporization with PlasmaJet. No visual evidence of
endometriosis remains. Note minimal depth of penetration al-
lows for superficial, yet complete treatment.
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lary and lymphatic channels in the subcutaneous fat, liver,
spleen, and kidney (Y. Parhomenko, S. Tartynsky, K.
Kachiken, and J. Gugenheim, A. Ianielli, unpublished
data).11–13
Although this is a preliminary study in a limited number of
patients considering feasibility and safety, neutral argon
plasma appears to possess unique characteristics that
make it a safe and useful tool for the treatment of endo-
metriosis. Within the limitations of a pilot study, plasma
energy appears to be efficacious and safe for the complete
vaporization of endometriotic implants and can be used
for the laparoscopic management of endometriosis. The
absence of electric current flow through the patient also
avoids potential complications, such as capacitive cou-
pling, arcing, and electric burns. Larger series considering
long-term outcomes will be needed to confirm these initial
findings.
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